Imagen de Portada

The presence of Y chromosome leads to the difference of cancer in patients with different sexes

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Yingqi Kuang, Wenhuan Sun, Long Zhang
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	MedComm
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nanomedicine for cancer patient‐centered care
por: Carlo Sorrentino, et al.
Publicado: (2024)

Targeting polymorphonuclear myeloid‐derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy
por: Shiqi Li, et al.
Publicado: (2024)

Circulating tumor DNA analysis for prediction of prognosis and molecular insights in patients with resectable gastric cancer: results from a prospective study
por: Zheng Liu, et al.
Publicado: (2025)

The combination of tumor mutational burden and T‐cell receptor repertoire predicts the response to immunotherapy in patients with advanced non–small cell lung cancer
por: Yalun Li, et al.
Publicado: (2024)

Magnetic resonance imaging‐based radiomics analysis for prediction of treatment response to neoadjuvant chemoradiotherapy and clinical outcome in patients with locally advanced rectal cancer: A large multicentric and validated study
por: TingDan Hu, et al.
Publicado: (2024)

Changes in L‐phenylalanine concentration reflect and predict response to anti‐PD‐1 treatment combined with chemotherapy in patients with non‐small cell lung cancer
por: Yaqing Liu, et al.
Publicado: (2025)

Comparison of genetic and epigenetic profiles of periodontitis according to the presence of type 2 diabetes
por: Junho Kang, et al.
Publicado: (2024)

Liquid biopsy for human cancer: cancer screening, monitoring, and treatment
por: Hao Wang, et al.
Publicado: (2024)

Cerebral Infarction: Epidemiology, Classification, Mechanisms, Diagnosis, and Management
por: Meibiao Zhang, et al.
Publicado: (2026)

Influence of TP53 mutation on efficacy and survival in advanced EGFR‐mutant non‐small cell lung cancer patients treated with third‐generation EGFR tyrosine kinase inhibitors
por: Zhonghan Zhang, et al.
Publicado: (2024)

Phase I clinical trial to assess safety and efficacy of Oraxol, a novel oral paclitaxel chemotherapy agent, in patients with previously treated metastatic breast cancer
por: Yunfang Yu, et al.
Publicado: (2025)

PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis
por: Zhenxiong Zhao, et al.
Publicado: (2025)

Tryptophan deficiency induced by indoleamine 2,3‐dioxygenase 1 results in glucose transporter 1‐dependent promotion of aerobic glycolysis in pancreatic cancer
por: Heng Liang, et al.
Publicado: (2024)

Metabolic reprogramming in cancer and senescence
por: Yuzhu Zhang, et al.
Publicado: (2025)

Left ventricular trabecular complexity for risk stratification of cancer therapy–related cardiac dysfunction in breast cancer
por: Hesong Shen, et al.
Publicado: (2025)

Bending and Scission: When the Membraneless Condensates Meet Endosome Membrane
por: Zhengkun Zhang, et al.
Publicado: (2025)

Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies
por: Yuxi Ma, et al.
Publicado: (2024)

The role of mesenchymal stem cells in cancer and prospects for their use in cancer therapeutics
por: Jian Tang, et al.
Publicado: (2024)

Multimodal data fusion AI model uncovers tumor microenvironment immunotyping heterogeneity and enhanced risk stratification of breast cancer
por: Yunfang Yu, et al.
Publicado: (2024)

RNA modifications in cancer
por: Han Wu, et al.
Publicado: (2025)

Circular RNAs in cancer
por: Yang Guo, et al.
Publicado: (2025)

Epigenetic reprogramming in gastrointestinal cancer: biology and translational perspectives
por: Yingjie Wang, et al.
Publicado: (2024)

Tumor‐associated exosomes in cancer progression and therapeutic targets
por: Xiaomin Liu, et al.
Publicado: (2024)

Critical roles and clinical perspectives of RNA methylation in cancer
por: Ganglei Li, et al.
Publicado: (2024)

Phospholipids with two polyunsaturated fatty acyl tails: an important driver of ferroptosis
por: Chu Lu, et al.
Publicado: (2024)

Booster vaccination: host preparation against Omicron challenge by innate immunity training
por: Lan Bai, et al.
Publicado: (2024)

Serotonin signaling: a new player and therapeutic target beyond Long‐haul coronavirus disease
por: Lan Bai, et al.
Publicado: (2024)

Cell death pathways: molecular mechanisms and therapeutic targets for cancer
por: Shaohui Wang, et al.
Publicado: (2024)

Targeting CDK4/6 suppresses colorectal cancer by destabilizing YAP1
por: Yalei Wen, et al.
Publicado: (2025)

NFKB2 mediates colorectal cancer cell immune escape and metastasis in a STAT2/PD‐L1‐dependent manner
por: Jiwei Zhang, et al.
Publicado: (2024)

Neutrophil extracellular traps in cancer
por: Yuxi Ma, et al.
Publicado: (2024)

Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
por: Lin‐Zhu Zhang, et al.
Publicado: (2024)

Development and validation of a point‐of‐care nursing mobile tool to guide the diagnosis of malnutrition in hospitalized adult patients: a multicenter, prospective cohort study
por: Nan Lin, et al.
Publicado: (2024)

New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication
por: Sha Qin, et al.
Publicado: (2024)

Engineered CARD11–PIK3R3 T‐cell therapies as weapons of cancer mass destruction
por: Wanlu Zhang, et al.
Publicado: (2024)

The biological essence of synthetic lethality: Bringing new opportunities for cancer therapy
por: Meiyi Ge, et al.
Publicado: (2024)

Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
por: Leilei Wu, et al.
Publicado: (2024)

Targeting the DNA damage response in cancer
por: Federica Guffanti, et al.
Publicado: (2024)

Natural killer cells in cancer immunotherapy
por: DanRu Wang, et al.
Publicado: (2024)

Single‐cell transcriptomics reveal the remodeling landscape of bladder in patients with obstruction‐induced detrusor underactivity
por: Jiawei Chen, et al.
Publicado: (2024)